These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7873374

  • 1. Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells.
    Dengler R, Münstermann U, al-Batran S, Hausner I, Faderl S, Nerl C, Emmerich B.
    Br J Haematol; 1995 Feb; 89(2):250-7. PubMed ID: 7873374
    [Abstract] [Full Text] [Related]

  • 2. Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.
    Pulford KA, Erber WN, Crick JA, Olsson I, Micklem KJ, Gatter KC, Mason DY.
    J Clin Pathol; 1988 Aug; 41(8):853-60. PubMed ID: 2844860
    [Abstract] [Full Text] [Related]

  • 3. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study.
    Resnitzky P, Shaft D.
    Br J Haematol; 1994 Oct; 88(2):357-63. PubMed ID: 7803282
    [Abstract] [Full Text] [Related]

  • 4. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
    Bendix-Hansen K, Nielsen HK.
    Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
    [Abstract] [Full Text] [Related]

  • 5. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Aug; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK, De Oliveira LZ, Pereira Wda V, Quintana IZ, Tabak DG, De Oliveira MS.
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G.
    Cytometry; 1997 Jun 15; 30(3):134-44. PubMed ID: 9222099
    [Abstract] [Full Text] [Related]

  • 8. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
    Bendix-Hansen K, Kaspersen Nielsen H.
    Scand J Haematol; 1983 May 15; 30(5):415-9. PubMed ID: 6304866
    [Abstract] [Full Text] [Related]

  • 9. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B, Kashyap A, Bennett JM.
    Br J Haematol; 1992 Jul 15; 81(3):374-7. PubMed ID: 1382546
    [Abstract] [Full Text] [Related]

  • 10. Correlation of morphological FAB classification and immunophenotyping: value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias.
    Boban D, Sucić M, Marković-Glamocak M, Uzarević B, Batinić D, Marusić M, Nemet D, Labar B, Hitrec V.
    Eur J Cancer; 1993 Jul 15; 29A(8):1167-72. PubMed ID: 8518029
    [Abstract] [Full Text] [Related]

  • 11. Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia.
    Nguyen PL, Olszak I, Harris NL, Preffer FI.
    Am J Clin Pathol; 1998 Aug 15; 110(2):163-9. PubMed ID: 9704614
    [Abstract] [Full Text] [Related]

  • 12. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb 15; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 13. Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme.
    Hoijer MA, Melief MJ, Calafat J, Roos D, van den Beemd RW, van Dongen JJ, Hazenberg MP.
    Blood; 1997 Aug 01; 90(3):1246-54. PubMed ID: 9242559
    [Abstract] [Full Text] [Related]

  • 14. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
    Garwicz D, Lennartsson A, Jacobsen SE, Gullberg U, Lindmark A.
    Haematologica; 2005 Jan 01; 90(1):38-44. PubMed ID: 15642667
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of acute myeloid leukemia and system Coulter VCS.
    Bruno A, Del Poeta G, Venditti A, Stasi R, Adorno G, Aronica G, Suppo G, Di Rienzo AM, Iazzoni R, Tribalto M.
    Haematologica; 1994 Jan 01; 79(5):420-8. PubMed ID: 7843628
    [Abstract] [Full Text] [Related]

  • 16. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E.
    Br J Haematol; 1992 Jun 01; 81(2):178-83. PubMed ID: 1322689
    [Abstract] [Full Text] [Related]

  • 17. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
    Zhang PJ, Barcos M, Stewart CC, Block AW, Sait S, Brooks JJ.
    Mod Pathol; 2000 Apr 01; 13(4):452-8. PubMed ID: 10786814
    [Abstract] [Full Text] [Related]

  • 18. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.
    Sperr WR, Jordan JH, Baghestanian M, Kiener HP, Samorapoompichit P, Semper H, Hauswirth A, Schernthaner GH, Chott A, Natter S, Kraft D, Valenta R, Schwartz LB, Geissler K, Lechner K, Valent P.
    Blood; 2001 Oct 01; 98(7):2200-9. PubMed ID: 11568008
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B.
    Leukemia; 1991 Apr 01; 5(4):315-21. PubMed ID: 2027298
    [Abstract] [Full Text] [Related]

  • 20. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P, Denning-Kendall PA, Erickson-Miller CL, Singha S, Evely R, Hows JM, Freeman SD.
    Br J Haematol; 2003 Nov 01; 123(3):420-30. PubMed ID: 14617000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.